Analyst consensus rating
BioLife Solutions Analyst Rating: Hold
Direct answer
BioLife Solutions's consensus rating is Hold.
4 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $31.00.
Forecast evidence checked October 18, 2026.
Get free BioLife Solutions email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $38.61
- Average price target
- $31.00
- High price target
- $31.00
- Low price target
- $31.00
- Low target gap
- -19.7%
- Target upside
- -19.7%
- High target gap
- -19.7%
- Target range width
- 0%
- Consensus rating
- Hold
- Analysts
- 4
- Evidence date
- October 18, 2026
- Valid through
- October 25, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for BioLife Solutions?
BioLife Solutions has a verified Hold consensus. The same dataset has an average price target of $31.00.
How far are BioLife Solutions's low and high targets from the recorded price?
The low target implies -19.7%, while the high target implies -19.7%.
How many analysts are included in BioLife Solutions's consensus?
The verified consensus includes 4 analysts.
How is BioLife Solutions's target upside or downside calculated?
The average target of $31.00 is divided by the recorded price of $38.61, then one is subtracted to produce -19.7%. This does not guarantee a future return.
When was BioLife Solutions's analyst forecast verified?
The data was verified on 2026-10-18. The dataset is valid through 2026-10-25.